Proto Labs Hits Analyst Price Target
Stock Performance: Proto Labs Inc (PRLB) shares have surpassed the average analyst 12-month target price of $50.00, currently trading at $53.47/share.
Analyst Reactions: Analysts may respond to the stock reaching the target by either downgrading their valuation or raising their target price, depending on the company's fundamental developments.
Diverse Analyst Targets: Within the Zacks coverage, there are varying analyst targets for PRLB, ranging from $45.00 to $54.00, with an average target reflecting a collective assessment.
Investor Considerations: The crossing of the average target price signals investors to evaluate whether the stock's valuation is justified for further investment or if it’s time to consider selling.
Get Free Real-Time Notifications for Any Stock
Analyst Views on PRLB
About PRLB
About the author
Protolabs (NYSE: PRLB) Schedules Q4 and Full Year 2025 Financial Results Release and Conference Call
- Earnings Release Schedule: Protolabs will issue its Q4 and full year 2025 financial results before market open on February 6, 2026, highlighting the company's ongoing growth potential in the rapid manufacturing services sector.
- Conference Call Timing: The company will host a conference call at 8:30 a.m. EST on the same day to discuss the financial results in depth, aiming to enhance transparency and bolster investor confidence.
- Webcast Availability: The call will be available via a simultaneous webcast on the investor relations section of the Protolabs website, ensuring global investors can access key information in real-time, thereby improving engagement with stakeholders.
- Replay Service: An audio replay will be available on the Protolabs website approximately two hours after the call ends, allowing investors who could not attend live to review the discussion, thus enhancing information accessibility and transparency.
Protolabs Substantially Increases Metal 3D Printing Capacity in the U.S.
Expansion of Manufacturing Capacity: Protolabs has significantly increased its U.S. manufacturing capacity for metal 3D printing in 2025, adding four large-format Colibrium Additive M2 printers to meet rising domestic demand, particularly in the medical, aerospace, and defense sectors.
New Facility and Certifications: The new printers are located in a 120,000 sq. ft. facility in Raleigh, N.C., which houses nearly 40 DMLS printers and has received ISO 13485 and AS9100D certifications to enhance its capabilities in producing high-quality metal components.
Industry Collaboration: Protolabs hosted an open house for leaders in the medical and aerospace industries to discuss how its advanced 3D printing technologies and engineering support can streamline product development and improve manufacturing processes.
Commitment to Innovation: Protolabs emphasizes its commitment to innovation by investing in new technologies and responding to customer needs, positioning itself as a preferred partner for rapid prototyping and final production in the evolving landscape of metal 3D printing.
